CDSCO recommends to suspend license of JLNH’s blood bank

[email protected]

Bhilai, Mar 28: After suffering allegations of negligence in blood transfusion, the most reputed and oldest hospital of the region – Jawahar Lal Nehru Hospital and Research Centre, Sector 9 is likely to face administrative actions including suspension of the license of its Blood Bank.

The Central Drugs Standard Control Organisation (West Zone) has issued letter to the licensing authority of the state with recommendations of suspension of the blood bank license. While talking to Central Chronicle, Assistant Drug Controller (Food and Drugs Administration, CG) Hiren Patel confirmed that they have received letter from CDSCO and the department is initiating actions in this direction.

Blood bank of BSP’s JLN Hospital is the biggest in the region with latest equipments and facilities in place. The blood bank has recently got its license renewed till 2021. But in the past few days it fell into controversies when a Raipur based person alleged that HIV infected blood was transfused to his new born baby. On the basis of the documents acquired through RTI, the aggrieved father claimed that HIV infested blood was transfused at JLN Hospital. He made complaint to various authorities after which a series of inspections were carried out.

Recently on March 12 and 13, a joint-investigation of the blood bank was carried out by the Inspectors of CDSCO, West Zone, Mumbai and Food & Drugs Administration, Durg, Chhattisgarh. During inspection various major non-compliances with respect to processing, testing and issuance of blood were observed by the investigating team.

In view of the non-compliances of standard procedure, including the serious observations with respect to issuance of blood without prior testing for HIV, HBsAg & HCV the joint-investigation team recommended for suspension of the license of the blood bank immediately. Accordingly, the CDSCO has recommended the State Licensing Authority (Food and Drugs Administration, Chhattisgarh) to take necessary action under Drugs and Cosmetics Act & Rules and suspend the license of the blood bank of JLN Hospital.

When contacted, BSP’s Chief of Communications Vijay Mairal informed that Bhilai Steel Plant management has not received any such information so far.

Show More

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Back to top button